Reveal HealthTech Raises $7.2 Million Series A to Accelerate AI-Driven Healthcare Solutions

Reveal HealthTech, a U.S.-based company focused on advancing healthcare through AI, engineering, and clinical strategy, has raised US$7.2 million in a Series A funding round led by Leo Capital, with participation from Sanos Capital.

The company was incubated in 2023 by W Health Ventures and 2070 Health, both of which remain key strategic partners supporting its continued expansion. Reveal HealthTech previously raised US$4 million in a seed round led by W Health Ventures to build its engineering, product, and clinical domain teams.

Reveal HealthTech provides AI-driven tools and services that help healthcare delivery systems, life sciences companies, and medtech organizations enhance efficiency and patient care. Its technology offerings include BioCanvas, a multimodal AI platform designed to accelerate clinical trial recruitment and support oncology research, and Prism AI, a solution that helps automate complex administrative and operational workflows in healthcare.

The company’s leadership includes co-founder Sanchit Mullick and Dr. Salim Afshar, along with a team of engineers and clinicians who bring deep experience across medicine, technology, and regulatory science. Their mission is to ensure that healthcare organizations can safely and effectively adopt AI solutions that are aligned with clinical realities and compliance standards.

With the new funding, Reveal HealthTech plans to scale its flagship products, expand its sales and customer success teams, and deepen its enterprise partnerships in the U.S. market. The company will also continue to grow its engineering and development operations in Bengaluru, India, to support product innovation and implementation.

Reveal HealthTech currently employs more than 120 professionals across its U.S. and India offices. Its hybrid approach—combining clinical insight, engineering talent, and AI expertise—has helped it attract a growing client base of hospitals, digital health companies, and research organizations seeking to integrate intelligent automation into their operations.

Investors have expressed confidence in the company’s model, highlighting its focus on delivering measurable business outcomes while maintaining a strong emphasis on clinical safety and regulatory integrity. Leo Capital emphasized Reveal HealthTech’s ability to provide “time-bound business goodness” by developing scalable and trustworthy technology solutions for healthcare enterprises. W Health Ventures noted that the company’s blend of healthcare understanding and technical excellence positions it uniquely to address critical gaps in AI adoption across the sector.

Reveal HealthTech’s growth reflects a broader trend within the global healthcare industry, where organizations are increasingly turning to specialized technology partners to modernize infrastructure, improve patient experiences, and manage data more effectively. The company’s AI and data platforms are designed not just to automate workflows, but to enhance clinical decision-making and streamline coordination between providers, payers, and researchers.

The Series A funding will enable Reveal HealthTech to further develop BioCanvas and Prism AI, integrate more advanced data analytics capabilities, and strengthen interoperability with existing healthcare systems. The company also intends to invest in research collaborations and pilot programs with major healthcare institutions to validate and refine its AI models.

Since its inception, Reveal HealthTech has positioned itself at the intersection of healthcare and deep technology, aiming to address systemic challenges such as staffing shortages, administrative inefficiencies, and the growing complexity of healthcare data management. By combining domain expertise with cutting-edge engineering and AI design, the company is building tools that promise both immediate operational benefits and long-term clinical impact.

With a total of US$11.2 million raised to date, Reveal HealthTech is poised to accelerate its mission of transforming healthcare organizations into more agile, data-driven, and patient-centered systems. The company’s expanding portfolio of AI-enabled platforms and partnerships signals its ambition to become a global leader in the healthcare technology ecosystem.